Health leaders from across the country took part in a
day-long global health discussion at Long Wharf Theater in
New Haven on January 29 devoted to Alzheimer's Disease, part of
the Global Health & The Arts series.
Co-Chairs
of the event were David Scheer, who is President, Scheer and
Company and Vice-Chair, Long Wharf Theatre; and Stephen
Strittmatter, who is a Director of Yale CNNR (the program in
Cellular Neuroscience, Neurodegeneration and Repair) and
Professor of Neurology at Yale University. CURE was a
sponsor of the event.
In
addition to hearing from speakers on the scientific and
human issues involved in the disease, the audience, which
included Connecticut Attorney General Richard Blumenthal,
saw a performance of Lil's 90th by Darci Picoult, a
new play about a family dealing with the mental decline of
its patriarch.
An
afternoon session included presentations by Larry Alstiel,
Vice President, Pfizer Neuroscience, and Husseini Manji,
Global Therapeutics Head, Neurosciences, Johnson + Johnson.
The
Alzheimer's forum also included:
- Dr.
Robert Alpern, Dean, Yale School of Medicine
- David
Holtzman, Chairman of Neurology, Washington University
- Lennart
Mucke, Head, Gladstone Institute of Neurology, UCLA
- Art
Horwich, Professor of Genetics and Pediatrics, Yale
- Marina
Picciotto, Professor of Psychiatry, Yale
- Pietro
De Camilli, Director Yale CNNR; Professor of Cell
Biology, Yale
- Sreegananga
Chandra, Asst. Professor of Neurology, Yale
- Amy
Arnsten, Professor of Neurobiology, Yale
- Mary
Tinetti, Professor of Medicine; Director Yale Program on
Aging
- Steven
Paul, President, Lilly Research Laboratories
- Howard
Feldman, Vice President and Therapeutic Area Head,
Global Clinical Research, Neuroscience, Bristol Myers
Squibb
Following dinner and the
performance of Lil's 90th, a post performance panel
introduced by Gordon Edelstein, Artistic Director of Long Wharf Theatre, included
Michael Fuchs, President of Concourse Health Sciences;
playwright Darci Picoult; and Vincent Marchesi, who is
Professor of Pathology and Professor of Cell Biology at
Yale, and Director of the Boyer Center for Molecular
Medicine.
In addition to CURE, sponsors of the event included Pfizer,
Inc., Johnson + Johnson, Bristol Myers Squibb, Boehringer
Ingelheim, Eli Lilly + Company, Yale New Haven Hospital, HB
Group, Genentech, and Connecticut Innovations.
|
